Urinary 11-dehydro-thromboxane B2 and coagulation activation markers measured within 24 h of human acute ischemic stroke
暂无分享,去创建一个
L. Williams | J. Biller | J. Meschia | J. Mcconnell | A. Bruno | J. D. Fleck | N. Bang | L. Cheryk | A. Durocher
[1] P. Koudstaal,et al. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. , 1997, Stroke.
[2] R. Tracy,et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1997, Stroke.
[3] M. Sata,et al. Protein C activation in NIDDM patients , 1996, Diabetologia.
[4] W. Feinberg,et al. Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. , 1996, Stroke.
[5] H. Asakura,et al. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. , 1996, Atherosclerosis.
[6] A. Terashi,et al. Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation. , 1995, Stroke.
[7] Rugman Fp,et al. Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors. , 1994 .
[8] R. Fanelli,et al. Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. , 1993, Clinical chemistry.
[9] J. V. van Wersch,et al. Prothrombin fragment 1.2 in both treated and untreated hypertensive patients. , 1993, The Netherlands journal of medicine.
[10] R. Fanelli,et al. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. , 1993, Prostaglandins.
[11] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[12] K. Takano,et al. Markers of a hypercoagulable state following acute ischemic stroke. , 1992, Stroke.
[13] M. Fisher,et al. Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity. , 1990, Archives of neurology.
[14] G. Davı̀,et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. , 1990, The New England journal of medicine.
[15] R. Barbarotto,et al. Prognostic significance of fibrinopeptide A in survivors of cerebral infarction. , 1990, Stroke.
[16] C. Dollery,et al. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. , 1989, Biochimica et biophysica acta.
[17] G. FitzGerald,et al. Paired analysis of urinary thromboxane B2 metabolites in humans. , 1987, Thrombosis research.
[18] B. Coull,et al. Enhanced in vivo platelet activation in subtypes of ischemic stroke. , 1985, Stroke.
[19] J. Fontcuberta,et al. Hemostatic disturbances in acute ischemic stroke: a study of 86 patients. , 1995, Acta haematologica.
[20] J. V. van Wersch,et al. Plasma Concentration of Coagulation and Fibrinolysis Factors and Platelet Function in Hypertension , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.